Zhang, Y., Li, Z., & Hao, Y. Comparative efficacy of GLP-1 RAs/SGLT-2 inhibitors in reducing cardiovascular events in type 2 diabetes according to baseline use of metformin: A systematic review and meta-analysis of randomized controlled trials. BMC.
Chicago Style (17th ed.) CitationZhang, Yuxin, Zhaoji Li, and Yongchen Hao. Comparative Efficacy of GLP-1 RAs/SGLT-2 Inhibitors in Reducing Cardiovascular Events in Type 2 Diabetes According to Baseline Use of Metformin: A Systematic Review and Meta-analysis of Randomized Controlled Trials. BMC.
MLA (9th ed.) CitationZhang, Yuxin, et al. Comparative Efficacy of GLP-1 RAs/SGLT-2 Inhibitors in Reducing Cardiovascular Events in Type 2 Diabetes According to Baseline Use of Metformin: A Systematic Review and Meta-analysis of Randomized Controlled Trials. BMC.